Cattapan Alana, Cohen Sara R
Department of Political Science, York University, Toronto, ON, Canada.
J Obstet Gynaecol Can. 2013 Jul;35(7):654-6. doi: 10.1016/s1701-2163(15)30890-2.
In June 2012, the Canadian House of Commons passed the so-called omnibus budget bill, making several important changes to the governance of assisted reproduction in Canada. The bill (Bill C-38) was widely criticized for its unwieldy size and rapid passage through Parliament, preventing adequate parliamentary debate and public scrutiny. Given the substantive nature of the amendments to the Assisted Human Reproduction Act made by Bill C-38, and the lack of relevant discussion about these changes both before and following its passage, this commentary is intended to identify how Bill C-38 may alter the governance of reproductive technologies in Canada. In this commentary, we address some of the more significant changes made by Bill C-38 to the regulation of reproductive medicine in Canada. We identify the benefits and challenges of closing Assisted Human Reproduction Canada, noting that doing so eliminates a much-needed forum for stakeholder consultation in this field. Further, we explore the implications of moving the regulation of donor semen from the Food and Drugs Act to the Assisted Human Reproduction Act; these include increased liability for physicians, and opportunities to expand the existing regulations to account for the needs of lesbian, gay, bisexual, trans, and queer Canadians using donor gametes and recent advances in reproductive technologies. Overall, we argue that although the implementation of a policy framework in this field remains highly dependent on yet-to-be written regulations, the changes to the Assisted Human Reproduction Act enabled by Bill C-38 may significantly alter how Canadians interact with reproductive technologies.
2012年6月,加拿大下议院通过了所谓的综合预算法案,对加拿大辅助生殖的管理做出了几项重要改变。该法案(C-38号法案)因其篇幅冗长且在议会迅速通过而广受批评,这使得议会无法进行充分辩论和公众监督。鉴于C-38号法案对《人类辅助生殖法案》所做修订的实质性内容,以及在其通过之前和之后都缺乏对这些变化的相关讨论,本评论旨在确定C-38号法案可能如何改变加拿大生殖技术的管理。在本评论中,我们探讨了C-38号法案对加拿大生殖医学监管所做的一些更重大的改变。我们指出关闭加拿大人类辅助生殖机构的利弊,注意到这样做消除了该领域急需的利益相关者协商论坛。此外,我们探讨了将供体精液监管从《食品和药品法》转移到《人类辅助生殖法案》的影响;这些影响包括医生责任增加,以及有机会扩大现有法规以满足使用供体配子的加拿大女同性恋、男同性恋、双性恋、跨性别和酷儿群体的需求以及生殖技术的最新进展。总体而言,我们认为,尽管该领域政策框架的实施仍高度依赖尚未制定的法规,但C-38号法案对《人类辅助生殖法案》所做的改变可能会显著改变加拿大人与生殖技术的互动方式。